A Unique Materials Platform for a Paradigm Shift in Cell Assaying
What We Do
Turning Adherent Cells into Reagents
Our SemaCyte® assaying microcarriers function as ultra-miniaturized, barcoded wells which can carry small colonies of adherent cells. They can be moved with liquid handling tools and are magnetically steerable.
Seamless Integration for Better and Faster Data
We introduce assay flexibility, miniaturisation, and multiplexing to drive 10x gains in drug screening. The SemaCyte® platform integrates with exisiting workflows and enables novel assaying formats.
Who We Are
Interfacing microchip-inspired hardware with the complex world of cell biology
Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications for unmet screening needs.
News
Featured
Technology
28th December 2022
Pine Trees Dancing to the Rhythm of Magnets
We made SemaCyte microcarriers in the shape of pine trees and loaded them with A549 lung carcinoma cells. After their release, we moved them around with an external magnetic field and dispensed them for an IC50 dose resp...
Read More
Business
22nd February 2022
Semarion raises £2.14m seed funding to commercialise cell assaying platform
Funding will support recruitment, commercial partnerships, and further development of Semarion’s SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel drug screening methodolo...
Read More
Business
25th June 2023
Semarion Featured on Cambridge University’s Innovation & Entrepreneurship Platform
IE Cambridge interviewed Semarion's CEO, Jeroen, and made a 2-min feature video about the innovation and entrepreneurial journey behind the company....
Read More
Our Partners
